Audit 29403

FY End
2022-06-30
Total Expended
$12.02M
Findings
2
Programs
2
Year: 2022 Accepted: 2023-02-23
Auditor: Moss Adams LLP

Organization Exclusion Status:

Checking exclusion status...

Findings

ID Ref Severity Repeat Requirement
37944 2022-001 Significant Deficiency - L
614386 2022-001 Significant Deficiency - L

Programs

ALN Program Spent Major Findings
93.498 Provider Relief Fund $11.75M Yes 1
93.461 Covid-19 Testing for the Uninsured $271,170 - 0

Contacts

Name Title Type
KKTVYMUW8Q29 Mitch Thomas Auditee
4243388717 Aparna Venkateswaran Auditor
No contacts on file

Notes to SEFA

Title: Note 1 Basis of Presentation Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Under the accrual basis of accounting, expenditures are recognized when incurred. Such expenditures are recognized following the cost principles contained in the Uniform Guidance wherein certain types of expenditures are not allowable or are limited as to reimbursement. The Hospital has not elected to use the 10 percent de minimis indirect cost rate as allowed under the Uniform Guidance. De Minimis Rate Used: N Rate Explanation: The auditee did not use the de minimis cost rate. The accompanying schedule of expenditures of federal awards (the Schedule) includes the federal grant activity of MLKLA Healthcare Corporation (the Hospital) under programs of the federal government for the year ended June 30, 2022. The information in this Schedule is presented in accordance with the requirements of the Title 2 U.S. Code of Federal Regulations (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of the Hospital, it is not intended to, and does not, present the financial position, results of operations, or cash flow of the Hospital. The Hospitals reporting entity is defined in Note 1 of the consolidated financial statements. All federal awards from federal agencies are included in the Schedule. The Schedule includes the grant income of the Hospital with the Tax Identification Number of 27-4658935.
Title: Note 3 Provider Relief Fund Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Under the accrual basis of accounting, expenditures are recognized when incurred. Such expenditures are recognized following the cost principles contained in the Uniform Guidance wherein certain types of expenditures are not allowable or are limited as to reimbursement. The Hospital has not elected to use the 10 percent de minimis indirect cost rate as allowed under the Uniform Guidance. De Minimis Rate Used: N Rate Explanation: The auditee did not use the de minimis cost rate. In accordance with guidance from the U.S. Department of Health and Human Services (HHS), the Hospital included the Reporting Period 2 (funds received between July 1, 2020 and December 31, 2020) expenditures for Provider Relief Fund Assistance Listing No. 93.498 of $11,750,000 in the Schedule for the year ended June 30, 2022, to align with HHS reporting guidelines. In accordance with U.S. GAAP, such amount of Provider Relief Fund Assistance received by the Hospital was recognized as revenue during the year ended June 30, 2021, and is included in beginning net assets as of and for the year ended June 30, 2022. No amounts were received or reported on related to Period 3 (funds received between January 1, 2021 and June 30, 2021).

Finding Details

Criteria: The Hospital should have appropriate internal controls in place to ensure that reporting requirements are met and amounts utilized in reports are calculated accurately and in accordance with 45 CFR 75.342. Condition and Context: When compiling the Period 2 Provider Relief Fund (PRF) that was submitted during the year ended June 30, 2022, the Hospital discovered expenses included within unreimbursed expenses attributable to Coronavirus on the Period 1 report that were not allowable and expenses that were applied towards other grants. The Hospital also identified additional expenses that should have been included within the Period 1 report. Additionally, there was one selection from our allowable cost testing that was included in both the Period 1 report and the Period 2 report. Cause: Expense amounts reported were not accurately reviewed prior to report submission. Effect: Errors were made in reporting quarterly expenses on both the Period 1 and Period 2 reports. However, we note there was no impact to total funding received or retained by the Hospital due to the error as the Hospital has additional unreimbursed expenses attributable to Coronavirus that could have been applied within the reports. The total amount of funding recognized under other provider relief fund expenses and the amount reported per the Schedule of Expenditures of Federal Awards were accurate. Questioned Costs: None. Repeat Finding: This is not a repeat finding. Recommendation: Policies and procedures over federal grant reporting should be modified to ensure reports are prepared using complete and accurate information. Review controls should be in place by someone other than the preparer of the report to ensure information is accurate prior to submission of the report. Views of Responsible Officials: Management will implement a process for the invoice detail to be reviewed for potential duplicate expenses by someone other than the preparer and a secondary cross validation of a sample set of data to ensure accuracy and compliance with reporting requirements.
Criteria: The Hospital should have appropriate internal controls in place to ensure that reporting requirements are met and amounts utilized in reports are calculated accurately and in accordance with 45 CFR 75.342. Condition and Context: When compiling the Period 2 Provider Relief Fund (PRF) that was submitted during the year ended June 30, 2022, the Hospital discovered expenses included within unreimbursed expenses attributable to Coronavirus on the Period 1 report that were not allowable and expenses that were applied towards other grants. The Hospital also identified additional expenses that should have been included within the Period 1 report. Additionally, there was one selection from our allowable cost testing that was included in both the Period 1 report and the Period 2 report. Cause: Expense amounts reported were not accurately reviewed prior to report submission. Effect: Errors were made in reporting quarterly expenses on both the Period 1 and Period 2 reports. However, we note there was no impact to total funding received or retained by the Hospital due to the error as the Hospital has additional unreimbursed expenses attributable to Coronavirus that could have been applied within the reports. The total amount of funding recognized under other provider relief fund expenses and the amount reported per the Schedule of Expenditures of Federal Awards were accurate. Questioned Costs: None. Repeat Finding: This is not a repeat finding. Recommendation: Policies and procedures over federal grant reporting should be modified to ensure reports are prepared using complete and accurate information. Review controls should be in place by someone other than the preparer of the report to ensure information is accurate prior to submission of the report. Views of Responsible Officials: Management will implement a process for the invoice detail to be reviewed for potential duplicate expenses by someone other than the preparer and a secondary cross validation of a sample set of data to ensure accuracy and compliance with reporting requirements.